The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5040799 6080046 I 5040799-7 20060629 20060630 DIR 73 YR F N 125 LBS 20060629 N N UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5040799 1007433099 PS FLUTICASONE PROPIONATE 1 NASAL 2 SPRAYS IN EACH NOSTRIL ONCE DAILY NASAL Y Y C224781 20080229

Indications of drugs used

Event ID DRUG SEQ INDI PT
5040799 1007433099 HYPERSENSITIVITY

Outcome of event

Event ID OUTC COD
5040799 OT

Reactions reported

Event ID PT
5040799 COUGH
5040799 EPISTAXIS
5040799 NASAL DRYNESS
5040799 PHARMACEUTICAL PRODUCT COMPLAINT
5040799 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5040799 1007433099 20060606 20060622 16 DAY